Phosphoric Acid Derivatives Group
These substances were identified for action under the Chemicals Management Plan (CMP). This screening assessment focuses on 3 of 6 substances referred to collectively as the Phosphoric Acid Derivatives Group.
|Substance group||CAS RN||Common name||DSL name||Draft screening assessment||Proposed conclusion on section 64 criteria||Follow-up activities|
|Phosphoric Acid Derivatives Group||25155-23-1||Trixylyl phosphate||Phenol, dimethyl-, phosphate (3:1)||HTML||Does not meet||Under consideration|
|37310-83-1Table 1 Footnote a||Oleyl phosphate||9-Octadecen-1-ol, (Z)-, phosphate||None planned at this time|
|119345-01-6Table 1 Footnote aTable 1 Footnote b||N/A||Phosphorous trichloride, reaction products with 1,1-biphenyl and 2,4-bis(1,1-dimethylethyl)phenol|
|July 2020||Anticipated publication of the final screening assessment.|
|July 13, 2019||Publication and start of 60-day public comment period on the Draft Screening Assessment for the Phosphoric Acid Derivatives Group. The related notice was published in the Canada Gazette, Part I: Vol. 153, No. 28.|
Three other substances were identified as being a part of the Phosphoric Acid Derivatives Group at the outset of the third phase of the CMP. These substances were subsequently determined to be of low concern to both human health and the environment, through other approaches. Conclusions for CAS RNs 68604-99-9, 68952-35-2, 111174-61-9 are provided in the Final Screening Assessment for the Rapid Screening of Substances with Limited General Population Exposure.
Report a problem or mistake on this page
- Date modified: